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The importance of open emergency surgery
in the treatment of acute mesenteric ischemia
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Abstract
Objective: Acute mesenteric ischemia (AMI) is a complex disease with a high mortality rate. A patient’s chance
of survival depends on early diagnosis and rapid revascularization to prevent progression of intestinal gangrene.
We reviewed our experience with open surgery treatment in 54 cases of AMI.
Methods: A monocentric retrospective study was conducted between 01/01/2001 and 04/30/2014; 54 AMI patients
with a mean age of 56.6 years underwent surgery (26 women and 28 men). Retrospectively, the risk factors,
management until diagnosis, vascular therapy and follow-up were evaluated.
Results: The symptom upon admission was an acute abdominal pain event. The delay time from admission to
surgery was, on average, 13.9 h (n = 34). The therapeutic procedures were open surgical operations. The
complication rate was (53.7 %) (n = 29). The 30-day mortality was 29.6 % (n = 16). The late mortality rate was 24.1 %
(n = 13), and the cumulative survival risk was 44.6 %. Survival was, on average, 60.54 months; however, in the over
70-year-old patient subgroup, the survival rate was 9.5 months (p = 0.035). The mortality rate was 27 % (n = 22) in
the <12 h delay group, 20 % (n = 5) in the 12–24 h delay group, and 50 % (n = 7) in the > 24 h delay group.
Conclusions: The form of therapy depends on the intraoperative findings and the type of occlusion. Although
the mortality rate has decreased in the last decade, in patients over 70 years of age, a significantly worse prognosis
was seen.
Keywords: Mesenteric ischemia, Mesenteric infarction, Superior mesenteric artery, Vascular reconstruction,
Endovascular treatment
Introduction
Cardiac arrhythmia with embolism is a frequent cause of
acute mesenteric ischemia (AMI). An acute closure of
the superior mesenteric artery (SMA) frequently leads to
irreversible damage of the intestinal mucosa within 6 h
[1]. The status of the celiac and SMA - celiac collaterals
as well as the hemodynamic status of the patient can be
important for AMI. Patients primarily present with an
acute pain event, which is followed by an interval of re-
duced pain intensity due to the decline of intramural
pain receptors arising from the hypoperfusion of the in-
testinal wall. As a result, this disease is often not initially
recognized as a vascular emergency, which leads to the
possibility of delays in making the appropriate diagnosis
and initiating treatment. Further along the course of the
disease, intestinal wall gangrene develops due to the de-
struction of the mucosal barrier, followed by bacterial
translocation, which may lead to peritonitis, sepsis and
multi-organ failure. Therefore, AMI comes with a high
mortality rate (50–70 %) [2]. Prognostic factors include
delays in diagnosis and in the revascularization of the
intestine, age of the patient and comorbidities [1].
AMI increases up to 10 % in patients older than
70 years with an acute abdomen [1]. Predisposing risk
factors include heart failure, coronary heart disease
(CHD), hypertension, peripheral arterial disease (PAD)
and location of the occlusion.
The mortality rate is directly correlated with the delay
interval, and in the case of rapid therapy, it is approxi-
mately 0–10 %. The mortality rate increases to 50–60 %,
with a delay of 6–12 h, and then to 80–100 % in cases
where the delay interval is greater than 24 h [3]. Periph-
eral vessel occlusion is associated with lower mortality
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than is central vessel occlusion because of the better col-
lateralization [3]. Non-occlusive mesenteric ischemia
(NOMI) represents a special form of vessel occlusion
that is caused by vasospasms of the mesenteric arterial
vessels. This form is more difficult to diagnosis than the
occlusive form and may therefore entail further delays.
The aim of this retrospective study is to describe AMI
as a vascular emergency in an effort to sensitize primary
clinicians in all disciplines. The study illustrates the
evaluation of risk factors, management until diagnosis,
vascular therapy and outcome.
Methods
In a retrospective study, 54 patients with AMI between
01/01/2001 and 04/30/2014 are presented. Patients who
developed AMI as a complication of other operations or
interventions were excluded from the study.
Mortality, morbidity, risk factors, management until
diagnosis, vascular therapy and outcome were retro-
spectively evaluated. Institutional Review Board approval
was waived because of the retrospective nature of the
study. All patients gave their written and informed con-
sent prior to surgery.
The patient characteristics (risk factors, cause of
occlusion, operational procedure, complications) are
summarized in Tables 1, 2 and 3.
Statistical analysis
Statistical analysis was performed in a logistic regression
for risk factors. The relationships between bypass, delay
interval and survival were assessed using the Fisher,
Kruskal-Wallis- and χ2-tests, as well as by cross tables.
Survival curves and survival distributions were determined
using the Kaplan-Meier method and the log-rank test.
The level of significance was defined at p <0.05. The SPSS
statistical package (IBM Corp. Released 2013. IBM SPSS
Statistics for Windows, Version 22.0. Armonk, NY: IBM
Corp.) was used for all statistical analyses.
Results
Patients presented at the clinic with an acute pain
event of the abdomen. The average age was 56.6 years
(11–85 years, of which 12 patients (22.2 %) were over
70 years old). The youngest patient (11 years old) had
cardiac arrhythmia with embolism and occlusion of the
abdominal aorta and SMA.
Diagnosis was provided by CT angiography with con-
trast medium (83.3 %, n = 45), conventional angiography
(53.7 %, n = 29), duplex sonography (27.8 %, n = 15) or
magnetic resonance imaging (MRI) (1.9 %, n = 1).
Altogether, a total of 45 out of 54 patients (83.3 %) had
leukocytosis (>10 000 /μl), 48 out of 52 patients (92.3 %)
had an increase of C-reactive protein (>0.5 mg/dl) and 18
out of 26 patients (69.2 %) had an increase of L-lactate
Table 1 Risk factor- dependent analysis of survival was
performed in a logistic regression
Variable n = 54 (%) P value
Age (mean ± SD) 56.61 ± 16.21 0.035
Gender 54 (100) 0.451
Arterial hypertension 31(57.4) 0.172
Coronary heart disease 15 (27.8) 0.959
Diabetes mellitus 11 (20.4) 0.567
Hyperlipidemia 10 (18.5) 0.564
Peripheral vascular disease 8 (14.8) 0.036
Smoking history 11 (20.4) 0.222
Arrhythmias 8 (14.8) 0.480
Second look 23 (42.6) 0.121
The level of significance was defined at p <0.05
SD Standard deviance
Table 2 Operational procedure and cause of occlusion of






Resection of the dissection membrane 11 (20.3)
SMA-transposition 7 (13.0)
Visceral surgery 8 (14.8)
Explorative laparotomy 3 (5.6)
Cause of occlusion
Arterial embolism 16 (29.6)
Arteriosclerosis combined with local thrombosis 13 (24.0)
Arterial thrombosis 12 (22.2)
Arterial dissection 9 (16.7)
Local dissection 2 (3.7)
Unclear cause of occlusion 2 (3.7)
Table 3 Complications after surgery
Parameter n (%)
Vascular occlusion 8 (14.8)
Ischemia of the gut 8 (14.8)
Acute kidney failure 6 (11.1)
Multi-organ failure 5 (9.2)
Wound healing disorder 5 (9.2)
Arrhythmias 3 (5.6)
Septic shock, respiratory failure, abdominal
compartment syndrome, rebleeding; each n = 2
8 (14.8)
Peritonitis, ileus, Leriche syndrome, Non occlusive
disease, liver failure, delirium, cholecystitis; each n = 1
7 (13.0)
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(>1.6 mmol/l). The delay from admission to surgery was,
on average, 13.9 h (n = 34, 63 %). In 20 patients, the delay
could not be determined. Logistical regression revealed
that PAD (p = 0.036) and age (p = 0.035) were the factors
with the greatest influence on survival (Table 1). The
30-day mortality was 30.8 % (n = 16), the late mortality
was 25 % (n = 13) and the overall mortality was 53.7 %
(n = 29). For the <12 h delay group, the mortality was
27.2 % (n = 22), and the mortality in the group with
12–24 h delay was 20 % (n = 5) and was 57.1 % (n = 7) in
the > 24 h after admission group. The delay interval was
known in 34 cases. Statistical analysis of the delay interval
using the crosstab test and the χ2 test did not reveal statis-
tical significance on survival (p = 0.42).
The cumulative survival risk was 44.6 %, with an aver-
age survival of 60.5 months (men: 70.2 months, women:
42.8 months) (Fig. 1). The log-rank test did not show a
significant effect of gender on survival (p = 0.529).
The under-70-year-old patient group had a survival-
time of 72.6 months, in contrast to the over 70 age
group, which only had a survival-time of 9.5 months.
Statistical analysis (log rank test) showed a significant
difference between the age groups (p = 0.035) (Fig. 2).
The causes of death during the early phase (<30 days)
included necrosis of the gut (n = 6), multi-organ failure
(n = 5), and other causes (n = 5). In the late phase
(>30 days), the causes of death included ischemia of the
gut (n = 2), other causes (n = 3), and unclear cause of
death (n = 8).
The primary patency rates were 80 % for transposition,
62 % for bypass, 53 % for TEA, and the secondary rates
were 77 % for grafts and 79 % for TEA. Overall, there
was no significant relationship (cross-tab, Fisher test, χ2
test and Kruskal-Wallis test) between the choice of the
bypass (“French bypass” or other bypass) and the choice
of the material (vein or alloplastic material) used in terms
of survival.
Twenty-five patients survived the AMI, whereas 7 pa-
tients could not be located for follow-up and 3 patients
refused the investigation.
The long-term results are based on 15 patients in the
follow-up (4 months - 9 years). During follow-up, one
patient complained about diarrhea and another patient
suffered from nausea and vomiting. A total of 13 pa-
tients (86.7 %) were asymptomatic and stated a positive
quality of life.
Discussion
The mortality in patients with AMI remains high despite
the diagnostic, surgical and endovascular developments
in recent decades. There was a decline in mortality rate
from 80–100 % in the 1970s to 50–70 % in the last dec-
ade. The decrease has been attributed to the better man-
agement of diagnosis and therapy [4]. The cause of
visceral ischemia is an important factor. The mortality
rate after surgical therapy for arterial embolism (54.1 %)
and venous thrombosis (32.1 %) in a meta-analysis of
Schoots et al. [5] was very high. This number rose after
surgical treatment for arterial thrombosis (77.4 %) and
NOMI (72.7 %). In our study, the 30-day mortality rate
was 30.8 %. Decisive factors that contribute to the sever-
ity of the disease are a late diagnosis, the resulting delay
in vascular therapy and the pre-existing co-morbidities
of many patients. An early diagnosis, prior to the
Fig. 1 Survival status of 54 patients with open surgical therapy
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development of bowel necrosis with peritonitis, is one of
the most important prognostic factors [6]. Statistical
analysis of the delay interval did not reveal statistical sig-
nificance on survival in our study because of the low
number of cases (n = 34).
CT scanning with contrast agents is the current gold
standard in instrument-based diagnostic testing, provid-
ing both high sensitivity and specificity. In contrast and
despite its high sensitivity and specificity, MRI requires
further development because of the longer duration of
the investigation and its low availability. It therefore
plays only a minor role in the diagnosis of peripheral
embolisms of the SMA, NOD and of acute mesenteric
ischemia [7, 8].
In cases of suspected AMI, the emergency diagnosis
should include biphasic contrast computed tomography
(CECT) with multi-planar reconstruction at 3 levels. The
venous phase of the CT is necessary for the diagnosis of
mesenteric vein thrombosis [9]. In our study, CT with
contrast agents was the gold standard in instrument-based
diagnostic testing, having replaced conventional angiog-
raphy as our imaging modality of choice.
Non-specific serum lactate is often used as a diagnos-
tic parameter. An elevated lactate level (>2.2 mmol/l) re-
flects the late phase of AMI with a transmural bowel
infarction, where release of lactate into the bloodstream
is caused by anaerobic metabolism with bacterial trans-
location. Serum lactate, however, cannot detect the early
phase where there is only damage to the intestinal mu-
cosa [10, 11]. Another serum parameter that can be used
for diagnosis is the D-dimer, which, although sensitive to
the early phase, has very low specificity [4].
As future biomarkers for the early phase of AMI, intes-
tinal fatty acid-binding protein (I-FABP), α-glutathione S-
transferase (GST) and D-lactate may play an important
role. I-FABP and GST are localized in the small intestinal
mucosa, whereas D-lactate is a natural degradation prod-
uct of intestinal bacteria. These markers may appear early
in the bloodstream if damage to the mucosa of the small
intestine occurs, leading to a loss of enterocytes as the first
sign of ischemia. However, the reliability of these serum
markers has yet to be demonstrated in randomized con-
trolled prospective studies [12]. In our daily clinical prac-
tice we used only L-lactate, leukocytosis and C-reactive
protein as parameters for AMI. Biochemical markers, such
as I-FABP, GST and D-lactate, must be further studied to
determine their roles as valid biomarkers for AMI, and
therefore, they cannot be used in daily clinical practice
[11, 12]. L-lactate, currently the most commonly used
marker, is not specific enough, however, and is only
present during the late phase of AMI [13].
In a thrombectomy or embolectomy, the thrombus is
recovered through a transaortic or transmesenteric
arteriotomy. The arterial occlusion is closed by either
direct suture or vein patch depending on the vessel
diameter. As atherosclerotic plaques cause occlusion of
the visceral arteries, these plaques can be removed either
indirectly transaortally or directly via an open endarter-
ectomy (TEA). Surgical access can be performed by a
laparotomy or through a thoracoabdominal approach
Fig. 2 Survival status oft he groups under and over 70 years of age
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[14]. An SMA transposition can be used for short
segment stenosis and occlusions of the SMA. Here, the
artery is discontinued and reinserted further distally into
the infrarenal aorta [15].
On the other hand, in cases of stenoses extending to a
large portion of the vessel wall, the bypass procedure is
the method of choice. The great saphenous vein or an
alloplastic material (PTFE, Dacron) are available as
bypass materials that may be applied antegrade or retro-
grade. In the retrograde procedure, where the origin of
the bypass is located distal to the SMA, the vessel sub-
stitutes should be guided behind the left renal vessels.
The renal vessels serve as a fulcrum to prevent kinking
of the bypass. Due to its complex correct anatomic de-
scription, this bypass is called the “French bypass”. The
“French bypass” combines the advantages of ante- and
retrograde visceral bypasses. The procedure allows distal
segments of the SMA to be reconstructed [16–18]. If the
lumen of the SMA is occluded due to a dissection mem-
brane that separates the true from the false lumen, the
membrane can be resected transaortally following direct
suturing of the aorta. In our center, we used all of these
surgical procedures (Table 1) and saw the best results
for transposition, with a primary patency rate of 80 %.
Overall, there was no significant relationship between
the choice of the bypass and the choice of the material
used in terms of survival. The results from the first
case series of 64 patients (1979–2000) were published
in 2002 [19]. Compared to our 2002 study [19], no
difference in terms of age, gender, risk profile or cause
of occlusion could be found in the present work. How-
ever, the new study showed a reduction in the overall
mortality rate, from 67 to 30 %, due to the improved
management of the diagnostic and treatment options.
The modern treatment of AMI should primarily be
performed by revascularization of the intestine.
A visceral surgical operation with bowel resection of
necrotic parts can be performed afterwards. In modern
vascular surgery, both endovascular and open surgical
treatment options should be considered.
Preoperatively, both clinical and CT morphological as-
pects must be considered, whether the patient presents
with peritonitis or an embolic or thrombotic occlusion
of the SMA. The endovascular treatment option is
recommended only in patients without peritonitis [1].
In the case of an AMI in combination with peritonitis,
exploratory laparotomy with vascular therapy is the
method of choice.
Five non-randomized studies have reported a comparison
between open and endovascular surgery. In a retrospective
study conducted within a single center, no difference in
mortality between the two methods could be shown [4].
However, another study reported lower morbidity and
mortality using the endovascular method [20]. Three
other multicenter studies were national supra-regional
studies: lower rates of bowel resection and lower mortality
and morbidity were seen in these studies for the endo-
vascular method [21, 22]. Therefore, if endovascular
therapy appears to be possible, this method should be
carried out whenever possible after the physician has
excluded peritonitis.
Open surgery can also be used in patients with peri-
tonitis in the late phase of AMI.
The poorer outcomes compared to endovascular proce-
dures are due to the poorer conditions of a late phase AMI.
Our study is, however, limited by its retrospective
nature and as a single center study in general validity.
Conclusions
AMI is an important differential diagnosis in acute ab-
domen. The diagnosis should be made by CT angiog-
raphy without a delay interval. The type of therapy
depends on the intraoperative findings and the type of
occlusion. In patients over 70 years of age, a significantly
worse prognosis was seen.
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